Hancock Jaffe Laboratories Inc ROCE
Что обозначает ROCE в Hancock Jaffe Laboratories Inc?
ROCE Hancock Jaffe Laboratories Inc является -27.53%
Какое определение для ROCE?
Рентабельность использованного капитала (ROCE) - это финансовый коэффициент, который измеряет прибыльность компании и эффективность использования ее капитала.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE компаний в Health Care сектор на NASDAQ по сравнению с Hancock Jaffe Laboratories Inc
Что делает Hancock Jaffe Laboratories Inc?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Компании с roce похож на Hancock Jaffe Laboratories Inc
- Compass имеет ROCE из -27.67%
- Lineage Cell Therapeutics Inc имеет ROCE из -27.63%
- Kuya Silver имеет ROCE из -27.62%
- Pender Street Capital Corp имеет ROCE из -27.61%
- Buckhaven Capital имеет ROCE из -27.61%
- Seagen Inc имеет ROCE из -27.58%
- Hancock Jaffe Laboratories Inc имеет ROCE из -27.53%
- Y-Mabs Therapeutics Inc имеет ROCE из -27.49%
- Ramco Systems имеет ROCE из -27.47%
- Goldflare Exploration Inc имеет ROCE из -27.46%
- Gravitas One Capital имеет ROCE из -27.44%
- Arcturus Therapeutics Inc имеет ROCE из -27.43%
- Bellus Health Inc имеет ROCE из -27.42%